These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 23080358

  • 1. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.
    Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, Kanungi J, Singh S, Haberer J, Priddy F, Sanders EJ.
    AIDS Behav; 2013 Jul; 17(6):2162-72. PubMed ID: 23080358
    [Abstract] [Full Text] [Related]

  • 2. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers.
    Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Priddy FH.
    PLoS One; 2012 Jul; 7(4):e33103. PubMed ID: 22511916
    [Abstract] [Full Text] [Related]

  • 3. Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand.
    Tangmunkongvorakul A, Chariyalertsak S, Amico KR, Saokhieo P, Wannalak V, Sangangamsakun T, Goicochea P, Grant R.
    AIDS Care; 2013 Aug; 25(8):961-7. PubMed ID: 23252473
    [Abstract] [Full Text] [Related]

  • 4. Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial.
    Kibengo FM, Ruzagira E, Katende D, Bwanika AN, Bahemuka U, Haberer JE, Bangsberg DR, Barin B, Rooney JF, Mark D, Chetty P, Fast P, Kamali A, Priddy FH.
    PLoS One; 2013 Aug; 8(9):e74314. PubMed ID: 24086333
    [Abstract] [Full Text] [Related]

  • 5. Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya.
    Mugo PM, Sanders EJ, Mutua G, van der Elst E, Anzala O, Barin B, Bangsberg DR, Priddy FH, Haberer JE.
    AIDS Behav; 2015 May; 19(5):794-801. PubMed ID: 25432877
    [Abstract] [Full Text] [Related]

  • 6. I Am Men's Health: Generating Adherence to HIV Pre-Exposure Prophylaxis (PrEP) in Young Men of Color Who Have Sex with Men.
    Daughtridge GW, Conyngham SC, Ramirez N, Koenig HC.
    J Int Assoc Provid AIDS Care; 2015 May; 14(2):103-7. PubMed ID: 25331226
    [Abstract] [Full Text] [Related]

  • 7. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial.
    Antoni G, Tremblay C, Delaugerre C, Charreau I, Cua E, Rojas Castro D, Raffi F, Chas J, Huleux T, Spire B, Capitant C, Cotte L, Meyer L, Molina JM, ANRS IPERGAY study group.
    Lancet HIV; 2020 Feb; 7(2):e113-e120. PubMed ID: 31784343
    [Abstract] [Full Text] [Related]

  • 8. Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.
    Sagaon-Teyssier L, Suzan-Monti M, Demoulin B, Capitant C, Lorente N, Préau M, Mora M, Rojas Castro D, Chidiac C, Chas J, Meyer L, Molina JM, Spire B, ANRS IPERGAY Study Group.
    AIDS Care; 2016 Feb; 28 Suppl 1(sup1):48-55. PubMed ID: 26883400
    [Abstract] [Full Text] [Related]

  • 9. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
    Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, Kallas EG, Chariyalertsak S, Grant RM, iPrEx investigators.
    Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
    [Abstract] [Full Text] [Related]

  • 10. Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.
    Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, Liu N, Harris DR, Mulligan K, Zimet G, Mayer KH, Anderson P, Kiser JJ, Lally M, Brothers J, Bojan K, Rooney J, Wilson CM.
    JAMA Pediatr; 2017 Nov 01; 171(11):1063-1071. PubMed ID: 28873128
    [Abstract] [Full Text] [Related]

  • 11. Real-time monitoring and just-in-time intervention for adherence to pre-exposure prophylaxis among men who have sex with men in China: a multicentre RCT study protocol.
    Jin X, Wang H, Li H, Chu Z, Zhang J, Hu Q, Lv W, Huang X, Chen Y, Wang H, He X, Zhang L, Hu Z, Bao R, Li S, Ding H, Geng W, Jiang Y, Shang H, Xu J, CROPrEP Study Team.
    BMC Public Health; 2020 Jul 24; 20(1):1160. PubMed ID: 32709230
    [Abstract] [Full Text] [Related]

  • 12. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas-Castro D, Cua E, Pasquet A, Bernaud C, Pintado C, Delaugerre C, Sagaon-Teyssier L, Mestre SL, Chidiac C, Pialoux G, Ponscarme D, Fonsart J, Thompson D, Wainberg MA, Doré V, Meyer L, ANRS IPERGAY Study Group.
    Lancet HIV; 2017 Sep 24; 4(9):e402-e410. PubMed ID: 28747274
    [Abstract] [Full Text] [Related]

  • 13. Factors Associated with Usage of Oral-PrEP among Female Sex Workers in Nairobi, Kenya, Assessed by Self-Report and a Point-of-Care Urine Tenofovir Immunoassay.
    Shah P, Spinelli M, Irungu E, Kabuti R, Ngurukiri P, Babu H, Kungu M, Champions TMFS, Nyabuto C, Mahero A, Devries K, Kyegombe N, Medley GF, Gafos M, Seeley J, Weiss HA, Kaul R, Gandhi M, Beattie TS, Kimani J.
    AIDS Behav; 2024 Nov 24; 28(11):3836-3849. PubMed ID: 39136824
    [Abstract] [Full Text] [Related]

  • 14. Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco.
    Gilmore HJ, Liu A, Koester KA, Amico KR, McMahan V, Goicochea P, Vargas L, Lubensky D, Buchbinder S, Grant R.
    AIDS Patient Care STDS; 2013 Oct 24; 27(10):560-6. PubMed ID: 24093809
    [Abstract] [Full Text] [Related]

  • 15. Knowledge of and interest in using preexposure prophylaxis for HIV prevention among men who have sex with men in Thailand.
    Sineath RC, Finneran C, Sullivan P, Sanchez T, Smith DK, Griensven Fv, Wimonsate W, Stephenson R.
    J Int Assoc Provid AIDS Care; 2013 Oct 24; 12(4):227-31. PubMed ID: 23708677
    [Abstract] [Full Text] [Related]

  • 16. From modeling to morals: imagining the future of HIV PREP in Lesotho.
    Kenworthy NJ, Bulled N.
    Dev World Bioeth; 2013 Aug 24; 13(2):70-8. PubMed ID: 23800326
    [Abstract] [Full Text] [Related]

  • 17. Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial.
    Mugwanya KK, Wyatt C, Celum C, Donnell D, Mugo NR, Tappero J, Kiarie J, Ronald A, Baeten JM, Partners PrEP Study Team.
    JAMA Intern Med; 2015 Feb 24; 175(2):246-54. PubMed ID: 25531343
    [Abstract] [Full Text] [Related]

  • 18. Sex, PrEP, and Stigma: Experiences with HIV Pre-exposure Prophylaxis Among New York City MSM Participating in the HPTN 067/ADAPT Study.
    Franks J, Hirsch-Moverman Y, Loquere AS, Amico KR, Grant RM, Dye BJ, Rivera Y, Gamboa R, Mannheimer SB.
    AIDS Behav; 2018 Apr 24; 22(4):1139-1149. PubMed ID: 29143163
    [Abstract] [Full Text] [Related]

  • 19. PrEP and the syndemic of substance use, violence, and HIV among female and male sex workers: a qualitative study in Kisumu, Kenya.
    Bazzi AR, Yotebieng K, Otticha S, Rota G, Agot K, Ohaga S, Syvertsen JL.
    J Int AIDS Soc; 2019 Apr 24; 22(4):e25266. PubMed ID: 30983147
    [Abstract] [Full Text] [Related]

  • 20. MPrEP+ study protocol: a prospective cohort study assessing the feasibility and acceptability of an HIV pre-exposure prophylaxis (PrEP) strategy for male clients of female sex workers in Kisumu, Kenya.
    Mantell J, Franks J, Zerbe A, Lamb MR, Reed DM, Omollo D, Lahuerta M, Naitore D, El-Sadr WM, Agot K.
    BMJ Open; 2022 Nov 04; 12(11):e064037. PubMed ID: 36332953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.